Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:01:25.363Z.
Calculation as of: 2026-10-06T15:01:25.363Z.
Quote observation: 2026-10-06T15:00:33.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 92e82853ec35d591c91e1857ba5f245e9338475f566e1ab86be3b7c1b83139db
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Artiva Biotherapeutics, Inc.
Market Cap
$346.77M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$352.79M
EV/FCF Ratio
N/A
TTM Avg
50.02x
3Y Avg
37.43x
5Y Avg
35.40x
Market Cap
$356.03M
EV/FCF Ratio
N/A
TTM Avg
6.23x
3Y Avg
6.23x
5Y Avg
6.23x
Market Cap
$336.05M
EV/FCF Ratio
N/A
TTM Avg
114948.95x
3Y Avg
114948.95x
5Y Avg
114948.95x
Market Cap
$356.59M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $346.77M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $352.79M | N/A | 50.02x | 37.43x | 35.40x |
| Opus Genetics, Inc. (IRD)vs › | $353.38M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $354.48M | 9.97x | 9.65x | 69.46x | 48.92x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.03M | N/A | 6.23x | 6.23x | 6.23x |
| Agenus Inc. (AGEN)vs › | $336.05M | N/A | 114948.95x | 114948.95x | 114948.95x |
| Ocugen, Inc. (OCGN)vs › | $356.07M | N/A | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $356.59M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $333.12M | N/A | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $324.51M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
